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A growing body of evidence suggests the alteration of the
reduction-oxidation (redox) homeostasis in the brain grown
with the increasing of the age. The brain is composed of
highly differentiated cells that populate different anatomical
regions and requires about 20% of body basal oxygen for its
functions [1]. Thus, it is not surprising that oxidative stress,
as well as alterations in brain energy metabolisms, have been
implicated in the pathogenesis of several neurodegenerative
diseases, including Alzheimer’s disease (AD), Parkinson’s
disease (PD), and amyotrophic lateral sclerosis (ALS). These
neurodegenerative disorders are typically characterized by
the progressive loss of neuronal cells and compromised
motor or cognitive functions. It has been shown that neuro-
nal cells are particularly vulnerable to oxidative damage due
to their high polyunsaturated fatty acid content in mem-
branes, high oxygen consumption, and weak antioxidant
defence. Cellular energy is mainly produced via oxidative
phosphorylation taking place within mitochondria, which
are crucial organelles for numerous cellular processes, such
as energy metabolism, calcium homeostasis, lipid biosynthe-
sis, and apoptosis [2, 3]. Glucose oxidation is the most rele-
vant source of energy in the brain because of its high rate of
ATP generation needed to maintain neuronal energy
demands [1]. Thus, neurons rely almost exclusively on the
mitochondria, which produce the energy required for most
of the cellular processes, including synaptic plasticity and
neurotransmitter synthesis [4].
This special issue contributes to original articles that
highlight and unravel mechanisms by which oxidative stress
and mitochondrial damage are implicated in neurodegenera-
tive diseases and provide new strategies that may counteract
these pathological processes.
The manuscript by A.A. Abubaker et al. highlights the
importance of NADPH oxidase activation and platelet oxida-
tive responses in the prothrombotic responses induced by
Aβ1-42, which is the β-amyloid peptide accumulating in
the brain of Alzheimer’s and Cerebral Amyloid Angiopathy
(CAA) patients. In addition to giving us some direction in
the elucidation of the molecular mechanisms underlying
platelet activation by β-amyloid peptides, this study suggests
a potential therapeutic opportunity aiming at limiting the
vascular component of Alzheimer’s disease by targeting
NADPH oxidase activity.
C.C. Cai et al. provides the first evidence that glycine, a
common substance present in numerous biomolecules,
attenuated hypoxic-ischemic injury in neurons or nervous
systems by decreasing mitochondria–mediated autophagy
through regulating the AMPK pathway.
J. Budziosz et al. investigated the effects of low-frequency
electromagnetic field (LFEMF) on the human body as elec-
tromagnetic sensitivity syndrome is commonly associated
with the rapid development of wireless technologies. Several
researchers have emphasised that exposure to EMF might
also cause increased ROS production and lead to oxidative
stress, which has been implicated in the pathogenesis of neu-
rodegenerative diseases. Regardless, the researchers did not
find any differences in lipid peroxidation, total oxidant sta-
tus, and antioxidant systems between the experimental and
Hindawi
Oxidative Medicine and Cellular Longevity
Volume 2020, Article ID 1270256, 2 pages
https://doi.org/10.1155/2020/1270256
control groups, suggesting that LFEMF did not affect oxida-
tive stress in the investigated brain structures.
K-I Tanaka et al. examined the effect of Ni2+ on Zn2+-
induced neurotoxicity, focusing on the endoplasmic reticulum
(ER) stress response, and found that carnosine (an endoge-
nous peptide) attenuated Ni2+/Zn2+-induced neuronal cell
death and ER stress occurring before cell death. Based on their
results, Ni2+ treatment significantly enhances Zn2+-induced
neuronal cell death by priming the ER stress response. Thus,
compounds that decrease the ER stress response, such as
carnosine, may be beneficial for neurological diseases.
The role of mitochondrial quality control (MQC) was
investigated by X. Jiang et al. This review focused on three
main aspects, that is, mitochondrial biogenesis, mitochon-
drial dynamics, and mitochondrial autophagy showing how
genetic and environmental factors result in PD pathogenesis
by interfering with MQC pathways, thereby hopefully con-
tributing to the discovery of novel potential therapeutic
targets for PD.
J. Han et al. examined the effects of paraquat (PQ), an
herbicide considered an environmental contributor to the
development of PD, inducing dopaminergic neuronal loss
through reactive oxygen species (ROS) production and oxida-
tive stress by mitochondrial complex I. Their findings indicate
that the inhibition of mitochondrial complex I with chloram-
phenicol (CP) protects dopaminergic neurons and may pro-
vide a strategy for preventing neurotoxin-induced PD.
Z. Wang et al. quantitatively pooled data on levels of
blood oxidative stress markers in ALS patients from the liter-
ature using a meta-analytic technique. They showed signifi-
cantly increased blood levels of 8-hydroxyguanosine,
malondialdehyde, and advanced oxidation protein product
as well as decreased glutathione and uric acid levels in the
peripheral blood of ALS patients. Thus, this meta-analysis
clarifies the oxidative stress marker profile in the blood of
ALS patients and strengthens the clinical evidence that pro-
oxidative imbalances contribute to ALS pathophysiology.
H-S. Lim et al. investigated the protective effects of Cica-
didae Periostracum (CP), the cast-off skin of Cryptotympana
pustulata Fabricius, on 1-8 methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine- (MPTP-) induced PD in mice and investigated
the underlying mechanisms of action, focusing on Nuclear
receptor-related 1 protein (Nurr1), a nuclear hormone recep-
tor implicated in limiting mitochondria dysfunction, apo-
ptosis, and inflammation in the central nervous system and
protecting dopaminergic neurons. They showed that CP
might contribute to neuroprotective signalling by regulating
neurotrophic factors primarily via Nurr1 signalling, neuroin-
flammation, and mitochondria-mediated apoptosis.
J.H. Cater et al. reviewed the ability of hypochlorite, an
oxidant that is generated during inflammation, to regulate
alpha-2-macroglobulin (α2M). This tetrameric protein is
constitutively abundant in biological fluids and is involved
in several biological processes, including the clearance of
the Aβ peptide.
In the end, the role of mitochondrial oxidative stress in
the aging process and neurodegenerative diseases has been
further explored by G. Cenini et al. The review tried to
summarize the molecular mechanisms involving mitochon-
dria and oxidative stress in the aging process with the aim
at identifying new strategies for improving a healthy and
extending lifespan.
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